Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Prevail Therapeutics to Present at Upcoming October Conferences
-
Prevail Therapeutics to Present at Upcoming October Conferences
-
Audentes Therapeutics to Participate in Upcoming Investor Conferences
-
Replimune to Present at Chardan’s 3rd Annual Genetic Medicines Conference
-
Editas Medicine to Participate in Upcoming Investor Conferences
-
Editas Medicine to Participate in Upcoming Investor Conferences
-
Replimune to Present at Chardan’s 3rd Annual Genetic Medicines Conference
-
Rocket Pharmaceuticals Announces Participation at the Chardan 3rd Annual Genetic Medicines Conference
-
CRISPR Therapeutics to Present at Upcoming Investor Conferences
-
Ocugen to Present at Three Upcoming Conferences
-
Synlogic to Present at the Chardan 3rd Annual Genetic Medicines Conference
-
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences
-
Celsion to Present at the Chardan 3rd Annual Genetic Medicines Conference
-
Celsion to Present at the Chardan 3rd Annual Genetic Medicines Conference
-
Homology Medicines to Participate in Conferences in October
-
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
-
IVERIC bio to Present at the Chardan Capital Markets 3rd Annual Genetic Medicines Conference
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardan's 3rd Annual Genetic Medicines Conference
-
Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
-
BiomX to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Translate Bio to Present at the 3rd Annual Chardan Genetic Medicines Conference
-
Translate Bio to Present at the 3rd Annual Chardan Genetic Medicines Conference
-
SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference
-
REGENXBIO to Present at The Chardan 3rd Annual Genetic Medicines Conference
-
ProQR to Present at Two Investor Conferences in October
-
PTC Therapeutics to Participate at Upcoming Investor Conferences
-
Chardan Capital Markets Starts Chardan Healthcare Acquisition Corp. (CHAC) at Buy
-
uniQure to Participate in Multiple Upcoming Industry Conferences in October
-
NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference
-
LogicBio Therapeutics to Present at October Conferences
-
LogicBio Therapeutics to Present at October Conferences
-
Arbutus to Participate in Upcoming Investor Conferences
-
Arbutus to Participate in Upcoming Investor Conferences
-
Precision BioSciences to Present at Upcoming Industry and Investor Conferences
-
Precision BioSciences to Present at Upcoming Industry and Investor Conferences
-
Dicerna™ to Present at Two Upcoming Investor Conferences
-
AGTC to Present at Upcoming Conferences
-
Voyager Therapeutics to Present at Upcoming Investor Conferences in October 2019
-
Moderna to Present at Upcoming Investor Conferences
-
Selecta Biosciences to Participate in Two Investor Conferences in October
-
Passage Bio to Present at Upcoming Investor Conferences
-
Passage Bio to Present at Upcoming Investor Conferences
-
UPDATE: Chardan Capital Markets Starts Minerva Neurosciences (NERV) at Buy
-
Form DEFM14A Chardan Healthcare Acqui
-
Form DEFA14A Chardan Healthcare Acqui
-
Form 8-K Chardan Healthcare Acqui For: Sep 23
-
MeiraGTx Holdings plc (MGTX) PT Raised to $45 at Chardan Capital Markets
-
Form 3 Chardan Healthcare Acqui For: Dec 18 Filed by: MMCAP International Inc. SPC
-
Form SC 13G Chardan Healthcare Acqui Filed by: MMCAP International Inc. SPC

